UCB-Pharma SA - Neupro 3 mg/24h, dispositif transdermique
57417
09
Neupro 3 mg/24h
dispositif transdermique
N04BC09
Rotigotine
05.03.2014
Composition
rotigotinum 6.75 mg, silicone adhesive, povidonum K 90, E 223, E 304, E 307, poly(ethylenis terephthalas), ad praeparationem pro 15 cm², cum liberatione 3 mg/24h.